Companies are adopting diverse approaches to reducing unwanted toxicities associated with cell and gene therapy.

Cell and gene therapies are opening new chapters for treating disease. By working with living cells and fine-tuning their ...

A procedure that could be done in half an hour, and prepared ahead of time, could seriously reduce blood loss from severe ...

An ELRIG webinar has explored how cell-based screening supports drug discovery, from early target validation to advanced ...

A single protein bolted to the inner membrane of a bacterial cell can shred a virus’s DNA before that genetic material ever reaches the interior. That is the central finding behind SNIPE, a newly ...

When scientist J. Craig Venter and his team announced in 2010 that they had created the first cell controlled by a fully synthetic genome, it marked a turning point in how scientists think about life.

McGill researchers have developed an AI tool called SIDISH that identifies high-risk cancer cells driving aggressive disease, enabling more precise and targeted treatment strategies. By linking single ...

The launch and operational start of the Eagle Line has enabled QuantumScape (NYSE:QS) to initiate commercial sampling and ...

Single-cell RNA sequencing is giving researchers a clearer view of why some CAR-T cells persist, expand, kill tumors ...

This review explains how glucose scarcity, lipid disruption, amino acid deprivation, and toxic metabolites weaken CAR-T cells ...

UC San Diego researchers have developed a new method that allows precise modification of any microbiome with prebiotics, ...

Cell Therapy Market Enters a New Era of InnovationThe Global Cell Therapy Market is valued at USD 11.21 Billion in 2022 and ...